In 2023, the share of corresponding/leading authors in biotechnology publications in China stood at 98.85. The forecasted data from 2024 to 2028 shows a consistent increase, reaching 99.11 by 2028. This presents a stable year-on-year growth between 0.05% and 0.06% every year, indicating a compound annual growth rate of approximately 0.06% over this period.
- The stable growth reflects China's emphasis on leading biotechnology research and prioritizing author contributions.
- Future trends to watch include the impact of government policies and international collaborations on author shares, as well as advancements in biotechnology that may influence publication dynamics.
